P038 AN OPEN-LABEL TRIAL OF INFLIXIMAB FOR INDUCING AND MAINTAINING CLINICAL AND ENDOSCOPIC REMISSION IN PATIENTS WITH ACUTE, SEVERE ULCERATIVE COLITIS

Autor:	S. Koilakou, I. Kalafatas, A. Roussos, G. Agalos, K. Papamichail, N. Apostolou, G.J. Mantzaris, E. Grivas, N. Kanellopoulos, Nikos Viazis, A. Christidou, D.G. Karamanolis
Rok vydání:	2008
Předmět:	medicine.medical_specialty business.industry Internal medicine medicine In patient Open label business medicine.disease Gastroenterology Ulcerative colitis Infliximab medicine.drug
Zdroj:	Journal of Crohn's and Colitis Supplements. 2:16-17
ISSN:	1873-9954
DOI:	10.1016/s1873-9954(08)70049-1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9466fa08ff0c094b444773d2e651ea11 https://doi.org/10.1016/s1873-9954(08)70049-1 Zobrazit plný text záznamu